Thromboembolic Complications in Takotsubo Cardiomyopathy

Abstract

Apical ballooning syndrome, commonly known as Takotsubo syndrome, is a distinct cardiomyopathy often resembling acute myocardial infarction in presentation. Takotsubo syndrome patients exhibit varied patterns of left ventricular wall motion abnormalities, most frequently apical dyskinesis with basal hyperkinesis, that are characteristically transient. Although emotional or physical stressors precipitate Takotsubo syndrome in most cases, a significant proportion presents without identifiable triggers, with a pronounced female predominance. Despite recovery of left ventricular function, Takotsubo syndrome may lead to serious complications akin to acute coronary syndromes. The pathophysiology remains incompletely understood, with catecholamine surge implicated in the genesis of myocardial injury, although direct causation remains debated. Diagnosis involves integrating clinical history, imaging modalities like echocardiography, and cardiac MRI. Psychiatric disorders, particularly anxiety and depression, are frequently associated with Takotsubo syndrome, suggesting a role of chronic stress in disease susceptibility. Management includes supportive care, with anticoagulation considered in cases of apical thrombus, alongside close monitoring for complications and recovery of left ventricular function. This article reviews the current understanding, challenges in diagnosis, and management strategies for Takotsubo syndrome.

Keywords

anxiety - anticoagulants - depression - psychiatric illness - stress cardiomyopathy - Takotsubo syndrome - thrombosis

Publikationsverlauf

Artikel online veröffentlicht:
08. Oktober 2024

• References

• 1 Ghadri JR, Wittstein IS, Prasad A. et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 2018; 39 (22) 2032-2046
• 2 Dawson DK. Acute stress-induced (takotsubo) cardiomyopathy. Heart 2018; 104 (02) 96-102
• 3 Ghadri JR, Wittstein IS, Prasad A. et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): diagnostic workup, outcome, and management. Eur Heart J 2018; 39 (22) 2047-2062
• 4 Templin C, Ghadri JR, Diekmann J. et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 2015; 373 (10) 929-938
• 5 Ghadri JR, Cammann VL, Napp LC. et al; International Takotsubo (InterTAK) Registry. Differences in the clinical profile and outcomes of typical and atypical Takotsubo syndrome: data from the International Takotsubo Registry. JAMA Cardiol 2016; 1 (03) 335-340
• 6 Singh T, Khan H, Gamble DT, Scally C, Newby DE, Dawson D. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications. Circulation 2022; 145 (13) 1002-1019
• 7 Lyon AR, Citro R, Schneider B. et al. Pathophysiology of Takotsubo syndrome: JACC state-of-the-art review. J Am Coll Cardiol 2021; 77 (07) 902-921
• 8 Donohue D, Movahed MR. Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome. Heart Fail Rev 2005; 10 (04) 311-316
• 9 Tornvall P, Collste O, Ehrenborg E, Järnbert-Petterson H. A case-control study of risk markers and mortality in Takotsubo stress cardiomyopathy. J Am Coll Cardiol 2016; 67 (16) 1931-1936
• 10 Sharkey SW, Windenburg DC, Lesser JR. et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010; 55 (04) 333-341
• 11 Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. [Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases]. J Cardiol 1991; 21 (02) 203-214
• 12 Kume T, Akasaka T, Kawamoto T. et al. [Relationship between coronary flow reserve and recovery of regional left ventricular function in patients with tako-tsubo-like transient left ventricular dysfunction]. J Cardiol 2004; 43 (03) 123-129
• 13 Ueyama T, Ishikura F, Matsuda A. et al. Chronic estrogen supplementation following ovariectomy improves the emotional stress-induced cardiovascular responses by indirect action on the nervous system and by direct action on the heart. Circ J 2007; 71 (04) 565-573
• 14 Scally C, Abbas H, Ahearn T. et al. Myocardial and systemic inflammation in acute stress-induced (Takotsubo) cardiomyopathy. Circulation 2019; 139 (13) 1581-1592
• 15 Al Houri HN, Jomaa S, Jabra M, Alhouri AN, Latifeh Y. Pathophysiology of stress cardiomyopathy: a comprehensive literature review. Ann Med Surg (Lond) 2022; 82: 104671
• 16 Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo syndrome. Circulation 2017; 135 (24) 2426-2441
• 17 Mizutani K, Shioya A, Hirose Y, Saito R, Yamada S. Serious takotsubo cardiomyopathy: an autopsy case presenting severe irreversible myocardial damage after frequent episodes of recurrence. Diagn Pathol 2020; 15 (01) 90
• 18 Nef HM, Möllmann H, Troidl C. et al. Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. Eur Heart J 2009; 30 (17) 2155-2164
• 19 Nef HM, Möllmann H, Akashi YJ, Hamm CW. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol 2010; 7 (04) 187-193
• 20 Nef HM, Möllmann H, Kostin S. et al. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 2007; 28 (20) 2456-2464
• 21 Wilson HM, Cheyne L, Brown PAJ. et al. Characterization of the myocardial inflammatory response in acute stress-induced (Takotsubo) cardiomyopathy. JACC Basic Transl Sci 2018; 3 (06) 766-778
• 22 Wittstein IS, Thiemann DR, Lima JA. et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005; 352 (06) 539-548
• 23 Khwaja YH, Tai JM. Takotsubo cardiomyopathy with use of salbutamol nebulisation and aminophylline infusion in a patient with acute asthma exacerbation. BMJ Case Rep 2016; 2016: bcr2016217364
• 24 Mendoza I, Novaro GM. Repeat recurrence of takotsubo cardiomyopathy related to inhaled beta-2-adrenoceptor agonists. World J Cardiol 2012; 4 (06) 211-213
• 25 Volz HC, Erbel C, Berentelg J, Katus HA, Frey N. Reversible left ventricular dysfunction resembling Takotsubo syndrome after self-injection of adrenaline. Can J Cardiol 2009; 25 (07) e261-e262
• 26 Litvinov IV, Kotowycz MA, Wassmann S. Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the “broken heart syndrome”. Clin Res Cardiol 2009; 98 (07) 457-462
• 27 Abraham J, Mudd JO, Kapur NK, Klein K, Champion HC, Wittstein IS. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 2009; 53 (15) 1320-1325
• 28 Jafari Giv M. Exposure to amphetamines leads to development of amphetamine type stimulants associated cardiomyopathy (ATSAC). Cardiovasc Toxicol 2017; 17 (01) 13-24
• 29 Fisk G, Hammond-Haley M, D'Silva A. Energy drink-induced cardiomyopathy. BMJ Case Rep 2021; 14 (04) e239370
• 30 Kaoukis A, Panagopoulou V, Mojibian HR, Jacoby D. Reverse Takotsubo cardiomyopathy associated with the consumption of an energy drink. Circulation 2012; 125 (12) 1584-1585
• 31 Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM. Catecholamine-induced cardiomyopathy. Endocr Pract 2008; 14 (09) 1137-1149
• 32 Iga K, Gen H, Tomonaga G, Matsumura T, Hori K. Reversible left ventricular wall motion impairment caused by pheochromocytoma—a case report. Jpn Circ J 1989; 53 (07) 813-818
• 33 Culerrier J, Terrier B, Groh M. et al. Takotsubo syndrome occurring in systemic diseases: a French multicenter retrospective case-control study and literature review. Autoimmun Rev 2024; 23 (02) 103483
• 34 Singh K, Marinelli T, Horowitz JD. Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system. Am J Emerg Med 2013; 31 (11) 1627.e1-1627.e4
• 35 Desai R, Parekh T, Raina J. et al. Takotsubo syndrome in patients with influenza infection or anti-influenza (flu) vaccination. Aging Health Res 2021; 1: 100024
• 36 Cobarro L, Valbuena-López S, Contreras C. et al. Immune checkpoint inhibitor-related stress cardiomyopathy: differential diagnosis and key role of cardiac imaging. JACC Case Rep 2023; 16: 101881
• 37 Y-Hassan S. S YH. Plasma epinephrine level and its causal link to Takotsubo syndrome revisited: critical review with a diverse conclusion. Cardiovasc Revasc Med 2019; 20 (10) 907-914
• 38 Angelini P, Uribe C, Tobis JM. Pathophysiology of Takotsubo cardiomyopathy: reopened debate. Tex Heart Inst J 2021; 48 (03) e207490
• 39 Citro R, Okura H, Ghadri JR. et al. Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE). J Echocardiogr 2020; 18 (04) 199-224
• 40 Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P. et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA 2011; 306 (03) 277-286
• 41 Levine GN, McEvoy JW, Fang JC. et al; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation 2022; 146 (15) e205-e223
• 42 Summers MR, Lennon RJ, Prasad A. Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential pre-disposing factors?. J Am Coll Cardiol 2010; 55 (07) 700-701
• 43 Kastaun S, Schwarz NP, Juenemann M. et al. Cortisol awakening and stress response, personality and psychiatric profiles in patients with takotsubo cardiomyopathy. Heart 2014; 100 (22) 1786-1792
• 44 Delmas C, Lairez O, Mulin E. et al. Anxiodepressive disorders and chronic psychological stress are associated with Tako-Tsubo cardiomyopathy—new physiopathological hypothesis. Circ J 2013; 77 (01) 175-180
• 45 Compare A, Bigi R, Orrego PS, Proietti R, Grossi E, Steptoe A. Type D personality is associated with the development of stress cardiomyopathy following emotional triggers. Ann Behav Med 2013; 45 (03) 299-307
• 46 El-Sayed AM, Brinjikji W, Salka S. Demographic and co-morbid predictors of stress (takotsubo) cardiomyopathy. Am J Cardiol 2012; 110 (09) 1368-1372
• 47 Nayeri A, Rafla-Yuan E, Krishnan S. et al. Psychiatric illness in Takotsubo (stress) cardiomyopathy: a review. Psychosomatics 2018; 59 (03) 220-226
• 48 Kastaun S, Gerriets T, Tschernatsch M, Yeniguen M, Juenemann M. Psychosocial and psychoneuroendocrinal aspects of Takotsubo syndrome. Nat Rev Cardiol 2016; 13 (11) 688-694
• 49 Kido K, Guglin M. Drug-induced Takotsubo cardiomyopathy. J Cardiovasc Pharmacol Ther 2017; 22 (06) 552-563
• 50 Y-Hassan S. S YH. Serotonin norepinephrine re-uptake inhibitor (SNRI)-, selective norepinephrine reuptake inhibitor (S-NRI)-, and exogenously administered norepinephrine-induced takotsubo syndrome: analysis of published cases. Int J Cardiol 2017; 231: 228-233
• 51 Christoph M, Ebner B, Stolte D. et al. Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. Eur Neuropsychopharmacol 2010; 20 (08) 594-597
• 52 Selke KJ, Dhar G, Cohn JM. Takotsubo cardiomyopathy associated with titration of duloxetine. Tex Heart Inst J 2011; 38 (05) 573-576
• 53 Narayanan A, Russell MD, Sundararaman S, Shankar KK, Artman B. Takotsubo cardiomyopathy following electroconvulsive therapy: an increasingly recognised phenomenon. BMJ Case Rep 2014; 2014: bcr2014206816
• 54 McCully RB, Karon BL, Rummans TA. et al. Frequency of left ventricular dysfunction after electroconvulsive therapy. Am J Cardiol 2003; 91 (09) 1147-1150
• 55 Beach SR, Wichman CL, Canterbury RJ. Takotsubo cardiomyopathy after electroconvulsive therapy. Psychosomatics 2010; 51 (05) 432-436
• 56 Messina AG, Paranicas M, Katz B, Markowitz J, Yao FS, Devereux RB. Effect of electroconvulsive therapy on the electrocardiogram and echocardiogram. Anesth Analg 1992; 75 (04) 511-514
• 57 Fuenmayor AJ, el Fakih Y, Moreno J, Fuenmayor AM. Effects of electroconvulsive therapy on cardiac function in patients without heart disease. Cardiology 1997; 88 (03) 254-257
• 58 Zhu WX, Olson DE, Karon BL, Tajik AJ. Myocardial stunning after electroconvulsive therapy. Ann Intern Med 1992; 117 (11) 914-915
• 59 Stöllberger C, Wegner C, Finsterer J. Seizure-associated Takotsubo cardiomyopathy. Epilepsia 2011; 52 (11) e160-e167
• 60 Kurisu S, Inoue I, Kawagoe T. et al. Incidence and treatment of left ventricular apical thrombosis in Tako-tsubo cardiomyopathy. Int J Cardiol 2011; 146 (03) e58-e60
• 61 Mitsuma W, Kodama M, Ito M. et al. Thromboembolism in Takotsubo cardiomyopathy. Int J Cardiol 2010; 139 (01) 98-100
• 62 de Gregorio C, Grimaldi P, Lentini C. Left ventricular thrombus formation and cardioembolic complications in patients with Takotsubo-like syndrome: a systematic review. Int J Cardiol 2008; 131 (01) 18-24
• 63 Baldetti L, Pagnesi M, Gallone G. et al. Thrombotic complications and cerebrovascular events in Takotsubo syndrome: a systematic review and meta-analysis. Can J Cardiol 2019; 35 (02) 230.e9-230.e10
• 64 Santoro F, Stiermaier T, Tarantino N. et al. Left ventricular thrombi in Takotsubo syndrome: incidence, predictors, and management: results from the GEIST (German Italian Stress Cardiomyopathy) registry. J Am Heart Assoc 2017; 6 (12) e006990
• 65 De Gennaro L, Ruggiero M, Musci S. et al. Biventricular thrombosis in biventricular stress(takotsubo)-cardiomyopathy. J Thromb Thrombolysis 2017; 44 (02) 234-237
• 66 Singh V, Mayer T, Salanitri J, Salinger MH. Cardiac MRI documented left ventricular thrombus complicating acute Takotsubo syndrome: an uncommon dilemma. Int J Cardiovasc Imaging 2007; 23 (05) 591-593
• 67 Matsuzono K, Ikeda Y, Deguchi S. et al. Cerebral embolic stroke after disappearing takotsubo cardiomyopathy. J Stroke Cerebrovasc Dis 2013; 22 (08) e682-e683
• 68 Garg P, van der Geest RJ, Swoboda PP. et al. Left ventricular thrombus formation in myocardial infarction is associated with altered left ventricular blood flow energetics. Eur Heart J Cardiovasc Imaging 2019; 20 (01) 108-117
• 69 Vasilieva E, Vorobyeva I, Lebedeva A. et al. Brachial artery flow-mediated dilation in patients with Tako-tsubo cardiomyopathy. Am J Med 2011; 124 (12) 1176-1179
• 70 Martin EA, Prasad A, Rihal CS, Lerman LO, Lerman A. Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol 2010; 56 (22) 1840-1846
• 71 Cecchi E, Parodi G, Fatucchi S. et al. Prevalence of thrombophilic disorders in takotsubo patients: the (ThROmbophylia in TAkotsubo cardiomyopathy) TROTA study. Clin Res Cardiol 2016; 105 (09) 717-726
• 72 von Känel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000; 65 (06) 357-369
• 73 Kontny F, Dale J, Abildgaard U, Pedersen TR. Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study. J Am Coll Cardiol 1997; 30 (04) 962-969
• 74 Vassiliki' Coutsoumbas G, Gallo P, Zagnoni S, Di Pasquale G. Long-term injury after Takotsubo syndrome (stress cardiomyopathy). Eur Heart J Suppl 2020; 22 (Suppl E): E73-E78
• 75 Byrne RA, Rossello X, Coughlan JJ. et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44 (38) 3720-3826
• 76 Medina de Chazal H, Del Buono MG, Keyser-Marcus L. et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol 2018; 72 (16) 1955-1971
• 77 Citro R, Rigo F, D'Andrea A. et al; Tako-Tsubo Italian Network Investigators. Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy. JACC Cardiovasc Imaging 2014; 7 (02) 119-129
• 78 Sharkey SW, Lesser JR, Zenovich AG. et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005; 111 (04) 472-479
• 79 Tsai TT, Nallamothu BK, Prasad A, Saint S, Bates ER. Clinical problem-solving. A change of heart. N Engl J Med 2009; 361 (10) 1010-1016
• 80 De Backer O, Debonnaire P, Gevaert S, Missault L, Gheeraert P, Muyldermans L. Prevalence, associated factors and management implications of left ventricular outflow tract obstruction in takotsubo cardiomyopathy: a two-year, two-center experience. BMC Cardiovasc Disord 2014; 14: 147
• 81 Parodi G, Del Pace S, Salvadori C, Carrabba N, Olivotto I, Gensini GF. Tuscany Registry of Tako-Tsubo Cardiomyopathy. Left ventricular apical ballooning syndrome as a novel cause of acute mitral regurgitation. J Am Coll Cardiol 2007; 50 (07) 647-649
• 82 Del Buono MG, Damonte JI, Moroni F. et al. QT prolongation and in-hospital ventricular arrhythmic complications in patients with apical ballooning Takotsubo syndrome. JACC Clin Electrophysiol 2022; 8 (12) 1500-1510
• 83 La Vecchia G, Del Buono MG, Sanna T. et al. Life-threatening arrhythmias in patients with Takotsubo syndrome: insights into pathophysiology and treatment innovations. JACC Clin Electrophysiol 2024; 10 (08) 1943-1952
• 84 Ghadri JR, Kato K, Cammann VL. et al. Long-term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol 2018; 72 (08) 874-882